7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole has been researched along with fluvoxamine in 1 studies
| Studies (7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole) | Trials (7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole) | Recent Studies (post-2010) (7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole) | Studies (fluvoxamine) | Trials (fluvoxamine) | Recent Studies (post-2010) (fluvoxamine) |
|---|---|---|---|---|---|
| 105 | 1 | 17 | 2,051 | 518 | 434 |
| Protein | Taxonomy | 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole (IC50) | fluvoxamine (IC50) |
|---|---|---|---|
| D | Rattus norvegicus (Norway rat) | 0.54 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0038 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.54 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, Y; Higashi, Y; Matsumura, H | 1 |
1 other study(ies) available for 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole and fluvoxamine
| Article | Year |
|---|---|
Determination of fluvoxamine in rat plasma by HPLC with pre-column derivatization and fluorescence detection using 4-fluoro-7-nitro-2,1,3-benzoxadiazole.
Topics: 4-Chloro-7-nitrobenzofurazan; Administration, Oral; Animals; Chromatography, High Pressure Liquid; Fluorescent Dyes; Fluvoxamine; Injections, Intraperitoneal; Injections, Intravenous; Male; Rats; Reproducibility of Results; Sensitivity and Specificity | 2005 |